Inotiv Inc (NOTV) NPV

Sell:$4.42Buy:$4.44$0.03 (0.78%)

Prices delayed by at least 15 minutes
Sell:$4.42
Buy:$4.44
Change:$0.03 (0.78%)
Prices delayed by at least 15 minutes
Sell:$4.42
Buy:$4.44
Change:$0.03 (0.78%)
Prices delayed by at least 15 minutes

Company Information

About this company

Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Key people

Robert W. Leasure
President, Chief Executive Officer, Director
Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
John Gregory Beattie
Chief Operating Officer
Jeff Krupp
Chief Human Resource Officer, Senior Vice President - Human Resources
Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Brennan Freeman
Vice President - Finance, Corporate Controller, Principal Accounting Officer
John E. Sagartz
Chief Strategy Officer, Director
Adrian Hardy
Chief Commercial Officer
R. Matthew Neff
Independent Chairman of the Board
Nigel Brown
Independent Director
Terry Coelho
Independent Director
Michael J. Harrington
Independent Director
David Landman
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US45783Q1004
  • Market cap
    $154.09m
  • Employees
    1,977
  • Shares in issue
    33.72m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.